Penumbra, Inc. (PEN): Price and Financial Metrics


Penumbra, Inc. (PEN): $125.70

1.18 (+0.95%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PEN POWR Grades


  • Stability is the dimension where PEN ranks best; there it ranks ahead of 53.65% of US stocks.
  • The strongest trend for PEN is in Growth, which has been heading down over the past 179 days.
  • PEN's current lowest rank is in the Growth metric (where it is better than 13.33% of US stocks).

PEN Stock Summary

  • PEN's current price/earnings ratio is 1,538.12, which is higher than 99.41% of US stocks with positive earnings.
  • Price to trailing twelve month operating cash flow for PEN is currently 855.34, higher than 99.28% of US stocks with positive operating cash flow.
  • With a year-over-year growth in debt of 124.58%, Penumbra Inc's debt growth rate surpasses 91.61% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Penumbra Inc, a group of peers worth examining would be NXGN, NARI, CUTR, TNDM, and OPRX.
  • Visit PEN's SEC page to see the company's official filings. To visit the company's web site, go to www.penumbrainc.com.

PEN Valuation Summary

  • In comparison to the median Healthcare stock, PEN's price/sales ratio is 294.74% higher, now standing at 15.
  • PEN's EV/EBIT ratio has moved up 3163 over the prior 72 months.
  • PEN's price/earnings ratio has moved up 1641 over the prior 72 months.

Below are key valuation metrics over time for PEN.

Stock Date P/S P/B P/E EV/EBIT
PEN 2021-08-31 15.0 14.8 632.6 1592.0
PEN 2021-08-30 14.7 14.6 622.4 1566.5
PEN 2021-08-27 14.8 14.6 625.3 1573.9
PEN 2021-08-26 14.7 14.5 619.8 1559.9
PEN 2021-08-25 14.7 14.5 619.8 1559.9
PEN 2021-08-24 15.0 14.9 634.5 1596.7

PEN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PEN has a Quality Grade of C, ranking ahead of 49.95% of graded US stocks.
  • PEN's asset turnover comes in at 0.794 -- ranking 38th of 186 Medical Equipment stocks.
  • IVC, NTUS, and MLSS are the stocks whose asset turnover ratios are most correlated with PEN.

The table below shows PEN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.794 0.618 0.009
2021-03-31 0.728 0.610 -0.030
2020-12-31 0.728 0.603 -0.054
2020-09-30 0.738 0.635 -0.038
2020-06-30 0.774 0.658 0.017
2020-03-31 0.880 0.676 0.079

PEN Price Target

For more insight on analysts targets of PEN, see our PEN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $319.80 Average Broker Recommendation 1.31 (Strong Buy)

PEN Stock Price Chart Interactive Chart >

Price chart for PEN

PEN Price/Volume Stats

Current price $125.70 52-week high $293.20
Prev. close $124.52 52-week low $114.86
Day low $121.85 Volume 298,800
Day high $126.36 Avg. volume 268,771
50-day MA $144.71 Dividend yield N/A
200-day MA $218.54 Market Cap 4.74B

Penumbra, Inc. (PEN) Company Bio


Penumbra Inc. is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. The company was founded in 2004 and is based in Alameda, CA.


PEN Latest News Stream


Event/Time News Detail
Loading, please wait...

PEN Latest Social Stream


Loading social stream, please wait...

View Full PEN Social Stream

Latest PEN News From Around the Web

Below are the latest news stories about Penumbra Inc that investors may wish to consider to help them evaluate PEN as an investment opportunity.

10 Stocks in Focus After Posting Their Earnings Reports

In this article, we will take a look at the 10 stocks in focus after posting their earnings reports. You can skip our detailed analysis of these companies and go directly to the 5 Stocks in Focus After Posting Their Earnings Reports. Recently, stocks from the consumer cyclical and healthcare sectors, including Lowe’s Companies, Inc. […]

Yahoo | February 24, 2022

Penumbra, Inc. (PEN) CEO Adam Elsesser on Q4 2021 Results - Earnings Call Transcript

Penumbra, Inc. (PEN) Q4 2021 Earnings Conference Call Feb 22, 2022, 04:30 PM ET Company Participants Jee Hamlyn-Harris - Investor Relations Adam Elsesser - President, Chairman and Chief Executive Officer Maggie Yuen - Chief Financial Officer Jason Mills - Executive Vice President, Strategy Conference Call Participants Robbie Marcus - JPMorgan...

SA Transcripts on Seeking Alpha | February 23, 2022

Wall Street Analysts Believe Penumbra (PEN) Could Rally 40%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 40.2% in Penumbra (PEN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Yahoo | February 23, 2022

Penumbra GAAP EPS of -$0.66 misses by $0.30, revenue of $204M beats by $9.71M

Penumbra press release (PEN): Q4 GAAP EPS of -$0.66 misses by $0.30.Revenue of $204M (+22.2% Y/Y) beats by $9.71M.

Seeking Alpha | February 22, 2022

Penumbra, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results

ALAMEDA, Calif., Feb. 22, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the fourth quarter and full year ended December 31, 2021. Financial Highlights: Revenue of $204.0 million for the

PR Newswire | February 22, 2022

Read More 'PEN' Stories Here

PEN Price Returns

1-mo -13.90%
3-mo -44.71%
6-mo -55.74%
1-year -54.05%
3-year -21.29%
5-year 44.40%
YTD -56.25%
2021 64.18%
2020 6.53%
2019 34.43%
2018 29.86%
2017 47.49%

Continue Researching PEN

Here are a few links from around the web to help you further your research on Penumbra Inc's stock as an investment opportunity:

Penumbra Inc (PEN) Stock Price | Nasdaq
Penumbra Inc (PEN) Stock Quote, History and News - Yahoo Finance
Penumbra Inc (PEN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6128 seconds.